The role of excitatory amino acids in experimental models of Parkinson's disease.
about
Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of ratsCytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.Glutamate receptors as therapeutic targets for Parkinson's disease.Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.Association between the low threshold calcium spike and activation of NMDA receptors in guinea-pig substantia nigra pars compacta neurons.
P2860
The role of excitatory amino acids in experimental models of Parkinson's disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The role of excitatory amino acids in experimental models of Parkinson's disease.
@en
type
label
The role of excitatory amino acids in experimental models of Parkinson's disease.
@en
prefLabel
The role of excitatory amino acids in experimental models of Parkinson's disease.
@en
P2860
P356
P1476
The role of excitatory amino acids in experimental models of Parkinson's disease
@en
P2093
Ossowska K
P2860
P2888
P356
10.1007/BF02250917
P50
P577
1994-01-01T00:00:00Z
P6179
1039103627